Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.48
-0.01 (-0.15%)
May 2, 2025, 12:18 PM EDT - Market open
Kura Oncology Employees
Kura Oncology had 192 employees as of December 31, 2024. The number of employees increased by 50 or 35.21% compared to the previous year.
Employees
192
Change (1Y)
50
Growth (1Y)
35.21%
Revenue / Employee
$354,120
Profits / Employee
-$947,328
Market Cap
561.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KURA News
- 4 hours ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 hours ago - Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 hours ago - Kura Oncology Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 days ago - Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST - GlobeNewsWire
- 8 days ago - Kura Oncology to Report First Quarter 2025 Financial Results - GlobeNewsWire
- 24 days ago - Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA - GlobeNewsWire
- 4 weeks ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Kura Oncology to Participate in Stifel Targeted Oncology Forum - GlobeNewsWire